Skip to main content
NIH funding notice RFA-CA-19-003

Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)

Closed on December 17, 2018.

Posted
August 13, 2018
Close date
December 17, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,242,127 in first-year total cost, median $10,242,127.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 OTC-B (55)]1

Most frequent institutions

  1. RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
Competing awards under RFA-CA-19-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center1U54CA232561-01A1CRIPE, TIMOTHY PMARDIS, ELAINE RRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH$10,242,127ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.